Reporting from the frontiers of health and medicine
208 followers 72 件/週
Ambitious federal study failed to curb opioid deaths, NIH announces

In 2019, amid an ever-worsening drug crisis, the federal government launched a research study with an ambitious goal: to lower opioid overdoses in participating communities by 40% using evidence-based interventions like distributing naloxone and providing access to addiction medications. But communities that implemented the public health strategies...

Sun Jun 16, 2024 17:31
Opinion: I cried tears of loss and rage at the World Hepatitis Summit

At this year’s World Hepatitis Summit in Lisbon, Portugal, the World Hepatitis Alliance presented me with an award that recognized my leadership as the organization’s president and my advocacy efforts to “improve the lives of people living with viral hepatitis.” As the citation was read aloud, tears started to flow — not tears of joy and pride but of...

Sun Jun 16, 2024 14:04
Opinion: Readers respond to a plea for rare disease progress, vaccine-related injury, and more

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received...

Sat Jun 15, 2024 14:28
Novo Nordisk CEO agrees to Bernie Sanders’ demand to testify on Ozempic, Wegovy prices

WASHINGTON — Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before the Senate after Sen. Bernie Sanders threatened to subpoena the company over its pricing of the popular diabetes drug Ozempic and the obesity drug Wegovy, the Senate health committee announced Friday. The agreement is a finale to a farcical public back-and-forth over apparent...

Sat Jun 15, 2024 01:05
STAT+: Colorado board decides a pricey Novartis medicine is unaffordable

A blockbuster arthritis drug from Novartis may face a limit on what Colorado health plans pay for the medicine after a state board determined the injectable treatment is “unaffordable” for patients. The Colorado Prescription Drug Affordability Board voted Friday to grant the designation to Cosentyx, which is used to treat conditions such as plaque...

Sat Jun 15, 2024 00:03
Opinion: NIH needs reform and restructuring, key Republican committee chairs say

While the best parts of biomedical innovation are represented by ringing the bell at a cancer hospital after the final round of chemotherapy, the worst are reminiscent of Frankenstein’s monster. As investigators continue to gain insight into the early days of Covid-19, the origins of the pandemic may be still up for debate. In addition, congressional...

Fri Jun 14, 2024 19:58

自分のためのニュースフィードを組み立てよう

準備はよろしいですか?
14 日間のトライアルをはじめましょう。クレジットカードは不要です。

アカウントを作成